ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Kalamazoo, Michigan–based Vestaron has closed a $40 million series B financing round led by Novo Holdings, parent company of Novo Nordisk and Novozymes. Vestaron develops biopesticides based on peptides found in spider venom. The start-up says they could prove to be environmentally friendly alternatives to synthetic crop protection chemicals. The company thus far has two products: one for greenhouse pests such as thrips, whiteflies, aphids, and mites and another for lepidopterans such as moths.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X